XORTX Therapeutics Inc. (XRTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    XORTX Therapeutics Inc.

    NASDAQ: XRTX · Real-Time Price · USD
    0.82
    -0.01 (-0.61%)
    At close: Sep 08, 2025, 3:59 PM

    XORTX Therapeutics Income Statement

    Financials in CAD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 141.96K 75.27K 17.88K
    Gross Profit
    		 n/a -141.96K -75.27K -17.88K
    Operating Income
    		 -3.59M -4.81M -10.69M -4.14M
    Interest Income
    		 n/a 257.65K 101.37K n/a
    Pretax Income
    		 -4.76M -2.15M -6.99M -1.3M
    Net Income
    		 -4.76M -2.15M -6.99M -1.3M
    Selling & General & Admin
    		 3.33M 2.39M 2.29M 1.58M
    Research & Development
    		 264.29K 2.41M 6.49M 669.11K
    Other Expenses
    		 n/a 0.00 n/a n/a
    Operating Expenses
    		 3.59M 4.81M 9.86M 2.86M
    Interest Expense
    		 n/a n/a n/a 4.39K
    Selling & Marketing Expenses
    		 1.74M 1.33M n/a n/a
    Cost & Expenses
    		 3.59M 4.81M 9.86M 2.86M
    Income Tax Expense
    		 n/a n/a 0.00 4.39K
    Shares Outstanding (Basic)
    		 2.88M 1.98M 1.48M 1.09M
    Shares Outstanding (Diluted)
    		 2.88M 1.98M 1.48M 1.09M
    EPS (Basic)
    		 -1.65 -1.08 -4.72 -1.19
    EPS (Diluted)
    		 -1.65 -1.08 -4.72 -1.19
    EBITDA
    		 -3.71M -4.87M -9.41M -1.63M
    EBIT
    		 -3.76M -6.57M -9.49M -2.92M
    Depreciation & Amortization
    		 55.71K 141.96K 75.27K 17.88K

    Add to Watchlist